Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 06, 2022 11:47am
Private Placement
VANCOUVER, BC – May 6, 2022 – Replicel Life Sciences Inc. (the “Company” or “Replicel”) announces that the TSX Venture Exchange (the “Exchange”) has granted a thirty (30) day extension to the
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 02, 2022 11:08am
Dermal Injector
From Twitter March 18: "We are nearly finished preparations on an Early Adopter Program for Key Opinion Leaders in three continents for pre-clinical and clinical evaluations in different
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(1)
•••
toniZ1
X
View Profile
View Bullboard History
Comment by
toniZ1
on Jun 02, 2022 12:49am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Andrew Schutte increases position in Replicel
jepp... that's the bet ;-)
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on May 31, 2022 10:35pm
RE:RE:RE:RE:RE:RE:RE:RE:Andrew Schutte increases position in Replicel
Yeah that dude is not pumping his $$ into this stock for $1 stock price. He's thinking something much bigger, which gives me confidence i also think if Shiseido buys rch01, it'll be $200
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on May 30, 2022 2:25pm
RE:RE:RE:RE:RE:RE:RE:Andrew Schutte increases position in Replicel
Of course i would sell my Shares now For 1$ But i think of Schutte give us an offer to Buy our Shares For 1$ - Why he should do this? A) he wants to have the company For his own and is happy to
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on May 30, 2022 1:16pm
RE:RE:RE:RE:RE:RE:Andrew Schutte increases position in Replicel
Yes me too. That is why I continued to add shares over the past 5 years. At one time I had allusions of a $3.00 - $5.00 stock but not now. Now my thinking has changed. I
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on May 30, 2022 12:45pm
RE:RE:RE:RE:RE:Andrew Schutte increases position in Replicel
All very valid - but for me (and Likely all of us) i came into this thinking it would be an absolute cash cow... you're right, $1 is better than todays value. Was hoping this could be a ticket to
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on May 30, 2022 11:08am
RE:RE:RE:RE:Andrew Schutte increases position in Replicel
Genie29J I think the main thing that is happening here is we will not hear any update until this extended private placement closes on June 6th. In that way all the insiders will have their
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on May 29, 2022 11:16pm
RE:RE:RE:Andrew Schutte increases position in Replicel
Something is definitely brewing - this dude isn't dumping pocket change into this company for nothing part of me wonders if he takes this private and buys out all remaining shares. He has the
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on May 28, 2022 2:36pm
RE:RE:Andrew Schutte increases position in Replicel
Who knows ! The total shares controlled by Mainpointe may not include warrants as well which would make the percental controlled by the Schutte family even higher. The point here for me is
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on May 28, 2022 11:32am
Andrew Schutte increases position in Replicel
News Release from Stockwatch May 28th "Following the Transaction, Mr. Schutte owned the following securities: (i) 6,079,604 Shares held directly; (ii) 250,000 class A preference shares held
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on May 28, 2022 4:03am
RE:Filings on cedar
2022-05-2704:22 2022-05-04 $RP Schutte, Andrew 4 - Director of Issuer Direct Ownership Warrants 16 - Acquisition or
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Post by
MetzGER
on May 27, 2022 2:14am
Shiseido terminated License agreement
Replicel terminated the License agreement with Shiseido on October 18, 2021. does anybody know here: Which is the Last Date Shiseido is able to respond on this? Is there a fixed ending Date of
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on May 24, 2022 12:36am
BS
Total BS as we continue with this perfect example (Replicel) of stock market horse manure. Keep it going boys you are doing a great job of destroying what is left of our investment.
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >